Patient flow forecasting can have a significant impact on patient outcomes. Specialist forecasting software can support pharma companies in achieving accurate predictions for enhanced outcomes.
28th November 2023Read More
7th September 2023Read More
With the pharmaceutical industry becoming increasingly digital, what processes are needed to enhance collaboration, communication, and to unlock the value of digital tools to achieve business goals?
6th July 2023Read More
Epidemiological forecasting plays a crucial role in understanding disease trends and predicting their impact. The accuracy of these forecasts is influenced by various factors, primarily the quality and availability of data.
29th June 2023Read More
By including the wider competitive set in the forecasting process, pharmaceutical companies can observe and visualize trends and patterns more clearly. This approach can provide valuable insights, to make informed decisions and develop strategies.
14th June 2023Read More
Ultimately, the accuracy of the sales forecast directly impacts the quality of business decisions. A more accurate forecast provides a solid foundation for decision-making
2nd June 2023Read More
In today's rapidly evolving pharmaceutical landscape, accurate forecasting is more crucial than ever before. Within this era of rapid technological advancement, Artificial Intelligence (AI) has emerged as a transformative force within various industries, including pharma.
30th March 2023Read More
The field of pharmaceutical forecasting has changed significantly over the last few years. There has been a clear demand for better forecasting due to the dynamic nature of the pharmaceutical industry.
10th November 2022Read More
Automating manual processes to solve common forecasting challenges for New Product Planning (NPP) teams.
8th December 2022Read More
Generating accurate forecasts for rare diseases can be challenging, especially when the treatable population is in the hundreds and there is little data to get you from one number to the next.
7th April 2022Read More
J+D were approached by a global pharmaceutical company with a broad pipeline across rare diseases, who needed an improved forecasting approach to evaluate a new extension line in greater detail and gain valuable insight from affiliates.